The study aims to analyze and forecast the Interventional X-ray market in the United States, Europe, and select Asia-Pacific countries for 2016.
Market trends (utilization of conventional and emerging clinical applications, growth indicators, factors influencing ROI, critical unmet needs and potential game changing strategies, growth opportunities for fixed interventional X-ray and surgical C-arm systems, emerging clinical application trends, technology trends driving IXR growth, and future prospects); company profiles; competitive structure; market metrics; market share; revenues; and strategies.
• United States
• Europe: Western Europe (Germany, United Kingdom, Italy, France, Spain, Benelux, Scandinavia) and Eastern Europe (Poland, Czech Republic, Hungary, Bulgaria, Romania)
• Asia-Pacific (Australia, India, Japan, Thailand, Indonesia, Malaysia)
Fixed interventional X-ray sub-segment (single plane, bi-plane) and Surgical C-arm (Mobile and Mini C-arm), and by the three regions.
Market measurements are analyzed for the year 2014-2016 and forecasted up to 202. Revenue and year-on-year growth rates are provided by regions and market segments. Pricing range and growth trends by sub-segment for the base year are discussed. Furthermore, an extensive list of the must-watch manufacturers in the interventional X-ray space in 2016 is provided.
Interventional X-ray (IXR) has become ubiquitous in most secondary and tertiary care hospitals as a standard interventional and diagnostic tool for radiology and cardiology. Despite IXR being a matured segment, technological innovation in recent years has resulted in multi-modality integration that blends various clinical applications, which can be carried out using a single suite. With the advent of private hospitals and favorable reimbursements of health insurance, there is more demand for patient safety and high quality technologies, reduced hospitalization, and reduction in overall healthcare costs.
Globally, countries are emphasizing safety and outcomes caused by X-ray systems, reduced radiation, seamless workflow, and cost-competitiveness. These factors determine the growth of the interventional X-ray market.
Strategies, growth analysis, competitive landscape, and future focus are discussed for vendors (GE Healthcare, Philips Healthcare, Siemens Healthcare, EMD Medical Technologies, Technix, Stephanix S.A, Hologic Inc., Medtronic, BMI Biomedical International s.r.l., EcoRay, Eurocolumbus s.r.l., Intermedical S.r.l., Shimadzu Corporation, Simad S.r.l., and Ziehm Imaging GMBH).
The base year for the study is 2016, historic years (2014 and 2015) with 2017 to 2021 as the forecast period.